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Summary 
We have identified a target antigen in autoimmune cere- 
bellar degeneration, p-NAP, that is closely related to 
the J~-adaptin and I~-COP coat proteins. J~-NAP is a non- 
clathrin-associated phosphoprotein expressed exclu- 
sively in neurons, from E12 through adulthood, p-NAP 
is present in the neuronal soma and nerve terminal as 
soluble and membrane-bound pools and is associated 
with a discrete set of nerve-terminal vesicles. These 
results establish I~-NAP as a neuron-specific vesicle 
coat protein. We propose a model in which p-NAP me- 
diates vesicle transport between the soma and the 
axon terminus and suggest that J~-NAP may represent 
a general class of coat proteins that mediates apical 
transport in polarized cells. 
Introduction 
A unique approach to the identification of neuron-specific 
proteins is through the analysis of human autoimmune 
neurologic degenerations (AINDs). The best character- 
ized of these are paraneoplastic disorders (Posner and 
Furneaux, 1990; Darnell, 1994), in which ectopic expres- 
sion of neuron-specific proteins in tumors leads to an effec- 
tive anti-tumor immune response and, secondarily, to au- 
toimmune degeneration of neurons expressing these 
proteins. It is believed that a requirement for the immune 
reaction to these antigens in tumor cells is that they are 
normally sequestered from the immune system as neuron- 
specific proteins. Although the mechanism of neuronal 
degeneration is unclear, high titer antibodies present in the 
serum and cerebrospinal fluid (CSF) recognize discrete 
antigens by Western blot and immunohistochemical nal- 
yses. Thus, the identification and characterization of such 
antigens provides a means of understanding AIND and 
identifying neuron-specific proteins that are likely to play 
critical roles in the function and viability of neurons. 
A distinct subset of AIND target antigens localize to the 
nerve terminal. Several, including synapt0tagmin (Martin- 
Moutot et al., 1993), amphiphysin (DeCamilli et al., 1993; 
Folli et al., 1993), and glutamic acid decarboxylase (Soli- 
mena et al., 1988; Christgau et al., 1992; Darnell et al., 
1993; Solimena and DeCamilli, 1993), are associated with 
nerve-terminal vesicles. This suggests that nerve-terminal 
proteins, particularly vesicle-associated proteins, may be 
especially immunogenic or susceptible (or both) to autoim- 
mune attack, although no mechanism for such a sensitivity 
is known. Antibodies against glutamic acid decarboxylase 
(the enzyme that produces the neurotransmitter y-amino- 
butyric acid [GABA]) present in the CSF of patients with 
stiff-man syndrome may interfere with enzyme function, 
since GABA agonists reverse the neurologic disease 
symptoms (Howard, 1963). Thus, AIND antisera may be 
of particular value in identifying and characterizing func- 
tionally important proteins associated with nerve-terminal 
vesicles. 
Many proteins associated with intracellular vesicles in 
neurons are factors common to all cells (Rothman, 1994), 
and thus less likely to be candidate AIND antigens. A num- 
ber of vesicle-associated proteins, however, have been 
carefully documented to be neuron specific, including 
some synaptic vesicle proteins (DeBello et al., 1993; 
Greengard et al., 1993; Bajjalieh et al., 1994), t-SNARES 
(Bennett et al., 1992), SNAP proteins (Whiteheart et al., 
1993), and the autoantigens ynaptotagmin (Hilbush and 
Morgan, 1994) and amphiphysin (Lichte et al., 1992). An 
important subset of vesicle-associated proteins that regu- 
late intracellular vesicle traffic are the coat proteins, multi- 
subunit complexes that include both general and neuron- 
specific variants. AP-1 or AP-2 coat protein adaptors 
associate with clathrin in all cells to mediate vesicle trans- 
port from the plasma membrane (AP-2) or the lTans-GoIgi 
network (AP-1) to endosomes (Pearse and Robinson, 
1990); these coatomers consist of large adaptin proteins 
(m 6, 13', or y) noncovalently linked to smaller subunits 
(AP50 and AP17; Pearse and Robinson, 1990; Robinson, 
1994). Nonclathrin-associated coat protein complexes, 
COPI (Malhotra et al., 1989) and COPII (Barlowe et al., 
1994), mediate vesicle traffic within the endoplasmic retic- 
ulum-Golgi apparatus. One subunit of COPI, I3-COP, 
shows significant homology to ~-adaptin (Duden et al., 
1991 ; Serafini et al., 1991), suggesting functional similarity 
between these protein families. 
Neuron-specific variants of clathrin (Stamm et al., 1992), 
~-adaptin (Pley and Parham, 1993), and AP50 (Pevsner 
et al., 1994) have been described. Such variants may be 
related to the role of clathrin-coated vesicles (CCVs) in 
the nerve terminal, where they are involved in the reuptake 
of synaptic vesicles (Maycox et al., 1992), perhaps in part 
through an interaction between AP-2 and synaptotagmin 
(Zhang et al., 1994). The recycling vesicles are thought 
to reform by budding from an axonal endosome (Heuser 
and Reese, 1973), and this has been suggested to involve 
additional neuronal coat proteins (Matter and Mellman, 
1994; Mundigl and DeCamilli, 1994), although such pro- 
teins have not been identified. Neuron-specific oat pro- 
teins may also play a role in the sorting and transport of 
membrane proteins between the neuronal cell body and 
the axon terminus. For example, KIF1A and KIF2, kinesin 
motor proteins, mediate anterograde axonal transport of 
vesicles that contain different sets of nerve-terminal mem- 
brane proteins (Noda et al., 1995; Okada et al., 1995), 
suggesting that these proteins are sorted into different 
classes of vesicles in the cell body. 
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We have characterized an anti-neuronal antibody pres- 
ent in the serum and CSF of a patient with cerebellar de- 
generation that recognizes a neuronal protein distinct from 
target antigens previously described in cerebellar AIND 
(Darnell et al., 1991). Using this antiserum, we now report 
the cloning and characterization of the gene encoding the 
target antigen. The encoded protein is a unique non- 
clathrin-associated coat protein homologous to I~-adaptin 
and 13-COP, and its expression is neuron specific from 
early in development hrough adulthood. We have named 
this protein 13-NAP, for neuronal adaptin-like protein. I3-NAP 
exists as cytoplasmic and membrane-bound pools in the 
nerve terminal and cell body and is associated with nerve- 
terminal vesicles. These findings suggest a model in which 
I~-NAP plays an essential role in neuronal function as part 
Figure 1. The I3-NAP Gene Encodes a Novel 
Adaptin and the Target Antigen of Autoimmune 
Nb Antiserum 
(A) The predicted sequence of the full-length 
13-NAP protein is shown. The homology be- 
tween the N-terminus of p-NAP and the human 
and Drosophila I~-adaptin and rat {B-COP coat 
proteins is shown. Stippled regions correspond 
to conserved amino acids. A consensus e- 
quence shows amino acid identities between 
[?,-NAP and at least two of the related coat pro- 
teins. Several highly conserved blocks of 
amino acids are evident; one, WI (L/I) GEY 
(amino acids 520-525), present in all adaptins 
and ~,-COP, is boxed. 
(B) I~-NAP is homologous to ~,-adaptin and 
p-COP in the N-terminus (HEAD) of the protein. 
This homology consists of two well-demar- 
cated domains (gray regions under HEAD) cor- 
responding to amino acids 41-246 and 346- 
577; the homology with I~-COP is restricted to 
amino acids 418-577 (indicated by an aster- 
isk). The percent identities to I~-NAP in these 
two domains are shown and are separated by 
a 100 amino acid stretch unique to B-NAP. The 
C-terminus (TAIL) of B-NAP is divergent from 
other coat proteins and includes the autoim- 
mune epitope; the extent of XNbl and the 
GST-Nb clones is indicated. The epitope maps 
to a 142 amino acid stretch of hydrophilic resi- 
dues (gray box under TAIL), evident inthe hy- 
drophilicity plot below the diagram, which has 
a high antigenicity index. 
(C) A 450 bp fragment of the ~.Nbl clone was 
expressed as a GST fusion protein (GST-Nb). 
Purified GST-Nb protein (0.3 mg per lane) was 
run on SDS-polyacrylamide gel and blotted 
with either normal human serum at 1:125 dilu- 
tion (lane 1) or Nb antiserum at serial 2-fold 
dilutions from 1:250 (lane 2) through 1:16,000 
(lane 8). 
(D) Native human serum (lane 1) and a rabbit 
antiserum generated and affinity purified 
against GST-Nb (lane 2) reacted with a protein 
with an identical M, of -145 kDa in mouse 
brain extracts. 
1 2 
of a coat protein complex that regulates vesicle traffic be- 
tween the cell body and the axon terminus, and they raise 
the possibility that interference with the activity of this pro- 
tein results in cerebellar degeneration. 
Results 
The I~-NAP Gene Encodes a Cerebellar 
Degeneration Target Antigen 
Antiserum (Nb) from a patient with cerebellar degeneration 
(Darnell et al., 1991) was used to screen a human cerebel- 
lar cDNA expression library. One strongly reactive clone, 
XNbl ,  was identified from 106 plaques and found to encode 
a predicted open reading frame of 440 amino acids. This 
clone was used to screen several human brain cDNA li- 
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braries and identified overlapping clones encoding a pre- 
dicted open reading frame of 1081 amino acids (Figure 
1A). A translational initiation codon surrounded by a weak 
Kozak consensus sequence is present at bp 68, and a 
stop codon is present at bp 3359. Although no upstream 
stop codon was found, comparison of 500 bp of mouse 
and human cDNAs immediately downstream of the ATG 
at bp 68 reveals that they are highly conserved (90% nu- 
cleic acid identity and 100% amino acid identity; data not 
shown), while the sequences immediately upstream of this 
ATG are not conserved (36% nucleic acid identity and 8% 
amino acid identity)..-Fhese observations uggest that the 
3.4 kb composite cDNA sequence encompasses the full- 
length coding sequence for this gene. 
Analysis of the predicted amino acid sequence revealed 
significant homology in the N-terminal 577 amino acids to 
the coat proteins l~-adaptin and, to a lesser degree, B-COP 
(Figures 1A and 1B). The N-terminus of 13-NAP shares 
sequence similarity with ~-adaptins of all species and has 
weak homology to y-adaptin (data not shown); the greatest 
similarity is to the Drosophila and human 13-adaptins, to 
which it is 36% identical (50% similarity) in two regions 
(between amino acids 41-577), which are interrupted by 
a unique 100 amino acid domain (Figure 1B). This degree 
of sequence similarity is greater than that found between 
13-adaptin and I~-COP, which are - 17% identical over the 
N-terminal 450 amino acids (Duden et al., 1991). Within 
this conserved region, ~-NAP contains a 7 amino acid con- 
sensus sequence (Wl (L/I) GEY) found in all adaptins (a, 
]3, and y) and ~-COP (Figure 1A; Duden et al., 1991). The 
predicted B-NAP protein harbors no signal sequence or 
transmembrane domain and has many potential phos- 
phorylation sites. Taken together, these data indicate that 
the i~-NAP gene encodes a protein highly conserved 
throughout evolution that is likely to mediate some aspect 
of vesicle trafficking. 
The homology between B-NAP and the ~-adaptin and 
B-COP proteins ends abruptly in the C-terminus of I~-NAP 
(distal to amino acid 577; Figures 1A and 1 B). Variability 
in the C-terminal region of adaptin family members (c~, 13, 
and y) and J3-COP has been noted; while poorly under- 
stood, these domains may mediate specific protein-pro- 
tein interactions (Kirchhausen et al., 1989; Robinson, 
1994). kNbl begins within this C-terminal domain, at 
amino acid 647 of the full-length protein. Notably, the first 
142 (N-terminal) amino acids of kNbl are highly charged 
and have a high hydrophilicity and antigenicity profile (Fig- 
ure 1B). To test whether this 150 amino acid peptide frag- 
ment encoded the epitope reactive with Nb antiserum, we 
subcloned and expressed it as a glutathione S-transferase 
fusion protein (GST-Nb). The GST-Nb fusion protein was 
reactive with Nb antiserum at serum dilutions of up to 1: 
16,000 (Figure 1C) and with Nb CSF at dilutions of up 
to 1:500 (data not shown). No reactivity was seen with 
unrelated paraneoplastic sera or antisera from more than 
50 patients with small-cell ung cancer without neurologic 
disease at dilutions of 1:50. To define further the relation- 
ship between the kNbl clone and the neuronal antigen 
detected by Nb antiserum, we used the GST-Nb fusion 
protein to generate rabbit Nb antibodies and to affinity 
purify human and rabbit Nb antiserum. Affinity-purified 
rabbit Nb antiserum reacted with a mouse brain protein 
of the same molecular mass as the antigen recognized 
by native human Nb antiserum (Figure 1D). 
The affinity-purified human and rabbit Nb antisera were 
also used for immunohistochemical nalysis of adult 
mouse brains. Immunohistochemistry evealed high lev- 
els of B-NAP expression in the cytoplasm and processes 
of neurons throughout the central and peripheral nervous 
system, including but not limited to Purkinje, hippocampal, 
and cortical neurons (Figures 2A-2C; data not shown); 
this pattern of reactivity was identical to that seen with 
native Nb antiserum. In more darkly stained sections, I3-NAP 
reactivity could be detected in the molecular layer, but no 
reactivity was evident in glial cells or cells outside of the 
nervous system (Darnell et al., 1991 ; data not shown). These 
data support the conclusion that the kNbl clone encodes 
the antigen recognized by Nb autoimmune antisera. 
Cellular and Developmental Expression of B-NAP 
Immunofluorescence was performed to examine further 
the cellular localization of I~-NAP. Confocal laser images 
Figure 2. Detection of IB-NAP Expression by 
Immunohistochemistry 
(A-C) Frozen sections of adult mouse brain 
were labeled with human or rabbit affinity- 
purified Nb antibody, and labeling was de- 
tected by horseradish peroxidase-coupled 
secondary antibody. Immunoreactivity is evi- 
dent within the Purkinje neurons of the cerebel- 
lum (A) and throughout the hippocampus (13). 
At higher magnification, reactivity is evident 
within the neuronal cell body and processes 
of Purkinje neurons (C). !mmunoreactivity was 
blocked by an excess of GST-Nb fusion protein 
(data not shown), and normal human serum 
and preimmune rabbit serum showed no reac- 
tivity. 
(D and E) Confocal laser microscopy of mouse 
cerebellum, revealing diffuse reacti~'ity n Pur- 
kinje cell cytoplasm (P) and weaker eactivity 
in the molecular (M) and granular (G) layers; 
this contrasts with the punctate cellular stain- 
ing in Purkinje cells seen with the lysosomal 
membrane marker LAMP (E). 
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Figure 3. IJ-NAP mRNA Expression Is Specific to the Nervous System 
(A) A Northern blot containing human mRNA from the indicated tissues was probed with a 13-NAP riboprobe. The !5-NAP transcript, detectable 
only in brain, is approximately 4.2 kb. The blot was reprobed with a 13-actin probe to control for the presence of mRNA in other tissues. 
(B-G) In situ hybridization of I~-NAP mRNA in the mouse brain. 
(B) Sagittal section of an E14 mouse brain showing !3-NAP mRNA expression confined to nervous ystem structures, including the telencephalon 
(tele), cerebellum (cb), olfactory epithelium (oe), spinal cord (sc), dorsal root ganglia (drg), trigeminal ganglion (V), and glossopharyngeal gan- 
glion (IX). 
(C) High magnification f(B) demonstrates [5-NAP mRNAwithin the postmitotic neocortical neuronal layer (ctx), but not in the developing neuroepithel- 
ium (ne). 
(D and E) P0 mouse cerebellum, shown in dark field (D) and bright field (E) microscopy. D-NAP mRNA is evident in the postmitotic Purkinje neurons 
(Pc), but is absent from the developing external granular neurons (egl). 
(F and G) In adult mouse brains, #-NAP mRNA is abundant in Purkinje neurons (F) and hippocampus (G); reactivity can also be seen throughout 
the gray matter. 
of mouse cerebellum revealed that a significant fraction 
of the neuronal cell body staining of 13-NAP was cyto- 
plasmic, in contrast with the punctate staining of a lyso- 
somal membrane marker LAMP (Figures 2D and 2E). 
Weak 13-NAP im munoreactivity was also evident within the 
granular layer of the cerebellum (Figure 2D) in a pattern 
reminiscent of that seen with proteins localized to the axon 
terminus (McPherson et al., 1994). 
To analyze the tissue specificity of 15-NAP m RNA expres- 
sion, we performed Northern blot and in situ hybridization 
analyses using a I~-NAP riboprobe. On Northern blot analy- 
sis, a highly brain-specific transcript of 4.2 kb was de- 
tected; of seven other tissues probed, none expresses 
this RNA (Figure 3A). In situ hybridization confirmed and 
extended this observation; 13-NAP mRNA was specifically 
expressed in the nervous ystem of the developing mouse 
at all embryonic stages examined (embryonic day 12 
[E12], E14, E15, E17, postnatal day 0 [P0], and P8; Figure 
3B; data not shown). R-NAP m RNA was expressed in post- 
mitotic neurons throughout the central and peripheral ner- 
vous system; 13-NAP mRNA is absent from both the mitotic 
neuroepithelium of the developing neocortex (Figure 3C) 
and the mitotic external granular layer of the developing 
cerebellum (Figures 3D and 3E). In the adult mouse brain, 
fJ-NAP mRNA remained neuron specific and was detect- 
able in all neurons, with highest levels in cerebellar Pur- 
kinje (Figure 3F) and hippocampal neurons (Figure 3G). 
Biochemical Characterization of B-NAP 
The adaptor coat protein complexes AP-1 and AP-2 medi- 
ate vesicle transport in conjunction with clathrin coats 
(Robinson, 1994), while the COP proteins have been found 
in association with nonclathrin-coated vesicles (Serafini 
et al., 1991; Rothman, 1994). Within the brain, AP-2 has 
been demonstrated to associate with CCVs, including 
those involved in reuptake of synaptic vesicles in the nerve 
terminal (Maycox et al., 1992; Zhang, et al., 1994). We 
investigated whether I~-NAP is associated with brain CCVs 
by analyzing Western blots of purified porcine brain CCVs. 
15-NAP was not detected in CCV extracts, although we 
found (z-adaptin to be enriched in CCVs, as described pre- 
viously (Figure 4A; Prasad and Keen, 1991). Therefore, 
despite the high degree of homology between 13-NAP and 
13-adaptin, B-NAP appears to be present in brain as a non- 
clathrin-associated protein. 
Since I~-NAP contains several potential phosphorylation 
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Figure 4. Characterization f 13-NAP Protein and Its Cellular Local- 
ization 
(A) Western blots of whole brain extracts (-300 p.g) or purified CCVs 
(-4 p.g) probed with antibody to either 13-NAP (top) or (z-adaptin (bot- 
tom). I3-NAP is undetectable in CCV, while (~-adaptin s enriched. 
(B) Mouse brain extracts were immunoprecipitated with a control anti- 
serum (Buckanovich et al., 1993) or antibody to 13-NAP as indicated, 
incubated with [~'-32P]ATP, and analyzed by SDS-PAGE and autoradi- 
ography (in vitro). The strongly labeled band (arrow) comigrates exactly 
with ~,-NAP detected by Western blot analysis (data not shown). A 
small-ceil lung tumor cell line was metabolically abeled with inorganic 
=P and immunoprecipitated with a control antiserum or with antibody 
to [3-NAP (in vivo). 
(C) Cytoplasmic and membrane fractions from adult mouse brain ly- 
sates were analyzed for the presence of 13-NAP by Western blot before 
and after the addition of 3.0 mM calcium to extracts. 
(D) Brain lysate was incubated with [~,-32P]ATP, separated into cyto- 
plasmic and membrane fractions in the absence (lanes 1 and 3) or 
presence (lanes 2 and 4) of 3 mM calcium, and immunoprecipitated 
with Nb antiserum. 
sites and shares sequence homology with vesicular coat 
proteins that are phosphorylated (Keen and Black, 1986; 
Keen et al., 1987; Hurtley, 1993), we examined whether 
(3-NAP is phosphorylated. When mouse brain extracts 
were immunoprecipitated with Nb antiserum and immuno- 
precipitates were incubated with [~,-32P]ATP, a phosphory- 
lated band that comigrated exactty with (3-NAP was de- 
tected (Figure 4B). Similarly, when brain extracts were 
incubated with [~,-32P]ATP prior to immunoprecipitation, 
the same band was detected (data not shown). Phospho- 
amino acid analysis revealed that (3-NAP was phosphory- 
lated on serine and threonine in approximately a 5:1 ratio. 
Since no exogenous kinases were added to these extracts, 
these data demonstrate that (3-NAP either coimmunopre- 
cipitates with and is phosphorylated by a protein kinase 
or is autophosphorylated. To examine whether (3-NAP is 
phosphorylated in vivo, we metabolically labeled a small- 
cell lung cancer cell line expressing (3-NAP (Darnell et al., 
1991) with inorganic 3~p and immunoprecipitated (3-NAP. 
Immunoprecipitates with anti-Nb, but not with an irrelevant 
serum, contained phosphorylated (3-NAP (Figure 4B), 
demonstrating that (3-NAP is phosphorylated in vivo. 
Cellular Distribution of (3-NAP 
Adaptin and COP proteins cycle between unassembled 
cytoplasmic pools and assembled membrane-associated 
complexes, where they mediate vesicle transport func- 
tions (Robinson, 1994; Rothman, 1994). To determine the 
cellular distribution of (3-NAP, we examined mouse brain 
cytoplasmic and membrane fractions. Western blot analy- 
sis revealed that (3-NAP is present in roughly equal propor- 
tions in mouse brain cytoplasm (40o) and membrane 
(60°) (Figure 4C). A significant component of this cyto- 
plasmic pool is present in the neuronal cell soma, as evi- 
denced by confocal aser microscopy (see Figure 2D). Thus 
(3-NAP, like the adaptin and COP proteins, may cycle be- 
tween a cytoplasmic pool and a membrane-bound fraction. 
To investigate whether (3-NAP phosphorylation is related 
to its subcellular distribution, extracts were incubated with 
[7-32P]ATP, separated into cytoplasmic and membrane 
fractions, and immunoprecipitated with Nb antiserum. 
(3-NAP was efficiently phosphorylated in both cytoplasmic 
and membrane fractions (Figure 4D). When (3-NAP was 
immunoprecipitated from each fraction prior to incubation 
with [7-32P]ATP, both immunoprecipitates contained phos- 
phorylated (3-NAP (data not shown). These results demon- 
strate that both cytoplasmic and membrane-bound (3-NAP 
associate with a protein kinase. 
The addition of exogenous calcium to brain extracts im- 
ulates depolarization of a neuron and alters the cellular 
localization of proteins such as synapsin and dynamin 
within the nerve terminal (Sihra et al., 1989; Liu et al., 
1994). To examine whether the cellular distribution of 
(3-NAP might relate to neuronal activity, we added calcium 
to brain extracts prior to cellular fractionation and immuno- 
precipitation. The presence of 3 mM calcium resulted in 
a 4-fold decrease in the cytoplasmic fraction of either phos- 
phorylated (3-NAP (Figure 4D) or (3-NAP detected by West- 
ern blotting (Figure 4C). This effect was proportional to 
the amount of calcium added, since smaller shifts were 
observed with lower concentrations of calcium (data not 
shown). We cannot exclude the possibility that the disap- 
pearance of (3-NAP from the cytoplasm isdue to proteolytic 
degradation; however, we favor the interpretation that 
13-NAP shifts to the membrane in the presence of calcium, 
since EGTA was used throughout the preparation of these 
extracts and we do not detect any 13-NAP degradation 
products in the presence of calcium (Figure 4D). These 
data suggest that I~-NAP shifts its cellular localization dur- 
ing calcium influx in neurons. 
Localization of p-NAP in the Nerve Terminus 
The neuron-specific localization of (3-NAP led us to investi- 
gate whether the (3-NAP protein was present in the nerve 
terminal. Synaptosomes were prepared from mouse brain 
homogenates (Dunkley et al., 1986); (3-NAP was detected 
in each of the fractions from the purification, including 
the synaptosomal fraction (Figure 5A). To control for the 
integrity of the final synaptosomal preparation, we as- 
sayed for the presence of synaptic vesicle proteins (synap- 
sin and synaptophysin) and a somatodendritic marker 
(transferrin receptor) in each fraction (Cameron et al., 
1991; Mundigl et al., 1993). Synapsin and synaptophysin 
were detected in each fraction in levels comparable with 
(3-NAP, while the transferrin receptor was undetectable in 
either the crude synaptosome fraction (P2) or the purified 
synaptosomal fraction (Figure 5A). 
To determine the distribution of (3-NAP within the nerve 
terminal, we assayed for the presence of (3-NAP in highly 
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Figure 5. p-NAP Localization i the Nerve Terminus 
(A) Proteins from brain subcellular f actions obtained uring synapto- 
somal purification (H, homogenate; $1, supernatant; P2, crude synap- 
tosome; Ssome, purified synaptosome) were detected by Western blot 
analysis; a single filter was stripped and reprobed with antibodies for 
the indicated proteins (trans rec, transferrin receptor; SY38, synapto- 
physin). The synaptosome fraction was found to be essentially pure 
by electron microscopy (data not shown). 
(B) Fractions obtained uring the purification ofnerve-terminal vesicles 
were analyzed by Western blot for the presence of p-NAP, synapsin, 
and syntaxin. Crude synaptosomes (P3) and their supernatants ($3) 
were isolated from brain homogenates by differential centrifugation. 
P3 was lysed by osmotic shock and fractionated into a heavy mem- 
brane fraction (LP1), a light membrane fraction enriched in nerve- 
terminal vesicles (LP2), and its supernatant (LS2). The CPG fraction 
contains a population of nerve-terminal vesicles purified from LP2 by 
CPG chromatography. 
(C) Crude vesicles from LP2 fractions were resolved with an $1000 
gel filtration column. Aliquots (15 i11) of column fractions (as indicated) 
were directly spotted on nitrocellulose, incubated with the indicated 
antibodies, and visualized by chemiluminescence. SY38, synapto- 
physin. 
purified vesicle preparations by Western blot analysis. Fig- 
ure 5B shows the distribution of 13-NAP in fractions obtained 
during the purification of synaptic vesicles by chromatog- 
raphy on controlled pore glass (CPG) beads (Huttner et 
al., 1983); J3-NAP levels were compared with synapsin I, 
a synaptic vesicle protein, and syntaxin 1, a t-SNARE 
found in purified synaptic vesicles (Walch-Solimena et ai., 
1995). p-NAP is present in the supernatants (cytoplasmic 
pools) of partially purified synaptosomes (Figure 5B, lane 
$3) and partially purified synaptic vesicle fractions (lane 
LS2). The presence of 13-NAP in the $3 and LS2 soluble 
fractions is similar to that found with other nerve-terminal 
proteins that distribute between vesicle-bound and soluble 
pools, including dynamin and p145 (McPherson et al., 
1994). In contrast, synapsin and syntaxin are present only 
in the membrane fractions and purified vesicles (Figure 5B). 
~-NAP is also readily detected in the pu re vesicle fraction 
(Figure 5B, lane CPG), although it is not enriched. 13-NAP 
is not enriched in the CPG fraction relative to LS2 and 
LP2 fractions, suggesting that there is less G-NAP protein 
per vesicle than synapsin or syntaxin, that the association 
of ~-NAP with vesicles is labile (see Barlowe et al., 1994), 
or that it purifies with a distinct population of nerve-terminal 
vesicles. For example, dynamin and p145, which cycle 
between nerve-terminal vesicles and the cytoplasm, and 
KIF2, which binds to a subset of nerve-terminal vesicles, 
are deenriched in CPG-purified vesicles to a similar or 
greater degree than is J3-NAP (McPherson et al., 1994; 
Noda et al., 1995). 
To investigate whether ~-NAP purifies with a distinct 
population of nerve-terminal vesicles, we fractionated 
crude nerve-terminal vesicles (LP2) using an $1000 gel 
filtration column. Fractions from the column were assayed 
under nondenaturing conditions for the presence of 
clathrin, G-NAP, or the synaptic vesicle marker synapto- 
physin. 13-NAP is enriched in peak fractions (30-32) that 
elute between those enriched in clathrin (22-26) and syn- 
aptophysin (36-38) (Figure 5C). The specificity of reactiv- 
ity with I~-NAP antibody was confirmed by SDS-polyacryl- 
amide gel electrophoresis (SDS-PAGE) and Western blot 
analysis of column fractions. Furthermore, electron micro- 
scopic examination of fractions 20-46 revealed vesicles 
with morphologically distinct coats in the clathrin-contain- 
ing fractions (see below) and a progressive decrease in 
the size of vesicles in the later fractions. 
To localize ~-NAP within the nerve terminal and to deter- 
mine whether ~-NAP was directly associated with neuronal 
vesicles, we performed imrnunogold electron microscopy 
of purified synaptosomes. Plastic-embedded sections re- 
vealed G-NAP immunoreactivity in presynaptic nerve ter- 
mini (Figure 6A) and in axons (data not shown). Immu- 
noelectron microscopy of fixed cryosections revealed a 
similar pattern of reactivity, with better preservation of ves- 
icle morphology (Figure 6B); at high magnification, much 
of the 13-NAP reactivity was evident on or near nerve- 
terminal vesicles. 
Clathrin- and ~-NAP-enriched $1000 fractions were ex- 
amined for immunoreactivity with gold-conjugated 13-NAP 
antibody by negative-stain electron microscopy. Approxi- 
mately two thirds of the vesicles in the 13-NAP-enriched 
fractions showed staining (defined as at least five 10 nm 
gold particles per vesicle), while essentially no vesicles in 
the clathrin-enriched fraction were stained (Figures 6C- 
6F). An irrelevant gold-conjugated antibody showed no 
vesicle reactivity (data not shown). We conclude that 
13-NAP is present within the nerve terminal as both a cyto- 
plasmic pool and a vesicle membrane-bound fraction. 
Discussion 
A Neuron-Specific Coat Protein is a Target 
Antigen in Cerebellar Degeneration 
We have shown that antiserum from a patient with im- 
mune-mediated cerebellar degeneration (Darnell et al., 
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Figure 6. Immunoelectron Microscopic Local- 
ization of [~-NAP 
(A) Mouse brain synaptosomes reactive with 
anti-Nb antibody in plastic-embedded sections 
(magnification, 25,000 x). 
(B) Cryosections how IB-NAP reactivity near 
nerve-terminal vesicles (magnification, 44,000 x) 
Sections stained with no primary antibody or 
a control non reactive primary antibody showed 
no staining (data not shown), 
(C-E) Nerve-terminal vesicles eparated on an 
$1000 column were incubated with 10 nm gold- 
conjugated anti-Nb antibody and examined by 
negative-stain electron microscopy. Approxi- 
mately 67% (125 of 186) of vesicles from 13-NAP 
fractions (30-32) stained heavily (more than 
five gold particles per vesicle) and had an aver- 
age diameter of 65 nm Nonreactive vesicles 
in these fractions are also evident (E). Magnifi- 
cation in (C), 79,000 x ; in (D) and (E), 55,000 x. 
(F) Vesicles from a clathrin-enriched fraction 
(23) had a morphologically distinct coat and did 
not stain (magnification, 55,000 x ) 
1991) identifies a neuron-specific vesicle coat protein that 
we have named I3-NAP. The #-NAP cDNA encodes a 
unique protein with a predicted Mr of 120 kDa that has 
homology to the vesicle coat proteins 13-adaptin and 
#-COP. [~-NAP is most closely homologous with the human 
and Drosophila 13-adaptins (Ponnambalam et al., 1990; 
Camidge and Pearse, 1994), followed by #-adaptins of 
other mammals, yeast, and to a lesser degree I3-COP (Du- 
den et al., 1991). These homologies are restricted to the 
N-terminal 577 amino acids of 13-NAP. Since the N-ter- 
minus is thought to harbor the major signal for targeting 
adaptors to the vesicular membrane (Robinson, 1994), our 
results suggest that #-NAP binds to vesicle membranes 
by a mechanism shared by the adaptins and #-COP. 
The C-terminus of ~-NAP diverges from 13-adaptin and 
J3-COP, and, as suggested for #-adaptin (Kirchhausen et 
al., 1989), this unique region may mediate specific protein 
interactions. In 13-NAP, the C-terminal region contains an 
acidic and serine-rich stretch of amino acids that encodes 
the epitope for the cerebellar degeneration antibody Nb. 
Thus, if the Nb antibody is directly involved in cerebellar 
degeneration, a plausible mechanism would be by binding 
to and interfering with the function of this charged region of 
13-NAP. A likely role for this region isto mediate interactions 
with a positively charged protein domain. This suggestion 
is supported by the observation that ~-NAP shows a high 
degree of sequence similarity in this region to an acidic 
and serine-rich region of YNSRP, a protein which itself 
binds positively charged proteins (Lee et al., 1991). These 
observations uggest that by binding to a protein-interact- 
ing domain of #-NAP, the Nb antibody could abrogate pro- 
tein and ultimately neuronal function, leading to cerebellar 
degeneration. More generally, since vesicle-associated 
proteins within the nerve terminal consistently appear as 
target antigens in AIND, we speculate that antibodies gain 
access to the nerve terminal by an unknown mechanism 
and inhibit protein function there. 
~-NAP expression is restricted to the mouse nervous 
system throughout development and in adulthood. The 
early developmental expression of [3-NAP in postmitotic 
neurons at E12, prior to the bulk of synaptogenesis (Jacob- 
son, 1991), together with the localization of #-NAP to the 
nerve terminus, suggests that ~-NAP is important for both 
the development and maintenance of mature synapses. 
The restricted expression of 13-NAP to neurons at all times 
in development is consistent with the hypothesis that it is 
immunogenic because it is normally sequestered from the 
immune system. 
A Model for the Role of J~-NAP in Neurons 
We have found that #-NAP is part of a multisubunit coat 
protein complex; I3-NAP coimmunoprecipitates with p47 
(F. Simpson, L. S. N., R. B. D., and M. S. Robinson, unpub- 
lished data), a coat protein related to the AP50 adaptor 
subunit (Pevsner et al., 1994). #-NAP itself is present in 
both cytoplasmic and membrane fractions (Figures 2, 4, 
and 5), suggesting that the #-NAP coat protein complex 
cycles between assembled (membrane-associated) and 
unassembled (cytoplasmic) pools. Within the neuron, 
13-NAP localizes to both the cell body (Figure ,?) and the 
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Figure 7. Model for 13-NAP-Mediated Vesicle Transport 
~-NAP is believed to be one component of a multisubunit coat protein 
complex that includes p47B (see text). In both the neuronal celt body 
and the axon terminus, ~-NAP is depicted as a cytoplasmic pool that 
is recruited to nascent vesicles budding from endosomes. Membrane 
recruitment may be stimulated by neuronal depolarization a d in- 
creased intracellular calcium. An undefined signal, perhaps involving 
GTP hydrolysis (Rothman, 1994), is predicted to release 13-NAP back 
to the cytoplasmic pool. This model depicts 13-NAP as an apical sorting 
coat protein, sorting nascent vesicles from the cell body toward the 
axon terminus. 
axon terminus, where it directly associates with a subset 
of neuronal vesicles (Figures 5 and 6). Notably, p47 itself 
was isolated with an antibody made to isolated nerve- 
terminal vesicles (Pevsner et al., 1994). Taken together, 
these observations uggest that ~-NAP is a component 
of a new class of coat proteins that mediate the sorting 
and transport of vesicle membrane proteins between the 
neuronal cell body and the nerve terminus. 
One model for the function of such a neuron-specific 
coat protein (Figure 7) is that 15-NAP mediates anterograde 
sorting and transport of vesicle membrane proteins from 
the cell body to the axon terminus. Anterograde sorting 
to the axon terminus is thought to correspond to apical 
sorting in polarized epithelial cells (Rodriguez-Boulan and 
Powell, 1992; Ikonen et al., 1993; Mundigl and DeCamilli, 
1994). The localization of 13-NAP to both the cell body and 
the nerve terminus suggests that it might act as an apical 
sorting coat protein in neurons. Since apical transport may 
involve sorting through an endosome (Barroso and Sztul, 
1994; Matter and Mellman, 1994), 13-NAP may coat na- 
scent vesicle membrane proteins budding from endo- 
somes in the cell body prior to their transport o the axon 
terminus. Subsequent o budding, the 13-NAP coat protein 
complex might interact with anterograde motor proteins 
involved in vesicle transport such as KIF1A (Okada et al., 
1995). 
In this context, ~-NAP may also play a role within the 
nerve terminal itself. Electron microscopic studies of stim- 
ulated nerve terminals have revealed that vesicles recycle 
via axonal endosomes (Heuser and Reese, 1973). While 
clathrin and AP-2 adaptors appear to mediate the reuptake 
of nerve-terminal vesicles in the axon terminus, the vari- 
able morphology of such vesicles does not correspond 
to the homogenous ize of most nerve-terminal vesicles 
(Mundigl and DeCamilli, 1994). These observations ug- 
gest that additional coat proteins might mediate vesicle 
budding from axonal endosomes; the presence of 13-NAP 
in a membrane-bound and soluble pool in the nerve termi- 
nus is consistent with such a role. 
Finally, this model raises the possibility that ~-NAP may 
be a neuron-specific form of a general class of coat pro- 
teins involved in vesicle transport o the apical membrane 
surface of polarized cells. In support of this suggestion 
there is preliminary evidence of a coat protein with homol- 
ogy to 13-COP that is associated with endosomes in non- 
neuronal cells (see Matter and Mellman, 1994). Moreover, 
p47 has both neuron-specific (p47B) and generally ex- 
pressed (p47A) forms (Pevsner et al., 1994), suggesting 
that a ~-NAP-related protein may exist in nonneuronal 
cells. 
A second model for I~-NAP function is that it mediates 
retrograde, rather than anterograde, movement of vesicle 
membrane proteins from the axon terminus toward the 
cell body. In this model ~-NAP might function in a way 
similar to 13-adaptin, mediating budding and transport of 
plasma membrane receptor endocytic vesicles. Some 
studies have demonstrated nonclathrin-associated coated 
vesicles within the nerve terminal, which may represent a 
subpopulation of recycling synaptic vesicles or a separate 
endocytic pathway (Koenig and Ikeda, 1989; Takei et al., 
1995). A specific role for retrograde vesicle transport from 
the axon terminal to the cell body in neurons is also sug- 
gested by the observation that axonal projections are 
obliged to transport trophic factor-bound receptors, via 
receptor-mediated endocytosis, back to the neuronal 
soma in order to maintain neuronal viability (Curtis and 
DiStefano, 1994). Such endocytosed receptors may be 
targeted to specific compartments within the neuronal cell 
body, and thus might require specific vesicle coat proteins. 
Regulation of I~-NAP Function 
The phosphorylation of 13-NAP and its apparent shift to 
the membrane upon the addition of exogenous calcium 
suggest ways in which the function of I~-NAP may be regu- 
lated. A number of vesicle-associated proteins present in 
the nerve terminal cycle between the cytoplasm and mem- 
brane in a phosphorylation- and calcium-dependent man- 
ner (Sihra et al., 1989; Davletov et al., 1993; DeBello et 
al., 1993; Liu et al., 1994). Although we have not identified 
a protein kinase inhibitor that blocks I~-NAP phosphoryla- 
tion, 13-NAP and p47 coimmunoprecipitate under condi- 
tions used in our phosphorylation assays. Since AP50 is 
thought o harbor protein kinase activity (Keen and Black, 
1986; Keen et al., 1987), our results suggest the possibility 
that p47 similarly acts as a protein kinase coimmunopre- 
cipitating with and phosphorylating ~-NAP in brain extracts. 
Alternatively, 13-NAP may coimmunoprecipitate with an- 
other kinase involved in regulation of vesicle recycling in 
neurons. The disappearance of 13-NAP from the cytoplasm 
of neurons upon addition of exogenous calcium suggests 
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that neuronal  depolar izat ion, with its concomitant  rise in 
intracel lu lar  ca lc ium,  may promote  ves ic le  coat ing by 
13-NAP. 
Experimental Procedures 
Cloning and Sequencing of NAP cDNA 
Autoimmune antiserum was used to screen a cerebellar expression 
library (ATCC) as described previously (Buckanovich et al., 1993) to 
identify clone ;LNbl. The XNbl 1.4 kb EcoRI insert was subcloned 
into pBluescript (-) to yield pNB1, which was used to screen human 
cerebellar and hippocampal and mouse brain cDNA libraries (Stra- 
tagene) to obtain the complete human and mouse cDNA sequences. 
The cDNAs were sequenced on both strands by the dideoxy termina- 
tion method using a Sequenase kit (United States Biochemical). 
Fusion Protein and Affinity Purification of Nb Antiserum 
A 450 bp fragment of ;~Nbl was subcloned into pGEX-2T (Pharmacia) 
to produce a GST-tagged fusion protein, which was purified using 
glutathione-agarose beads (Pharmacia). Rabbit antiserum was pre- 
pared with GST-Nb protein further purified by Mono Q-Sepharose 
FPLC. Nb antiserum was affinity pu rifled with GST fusion protein cova- 
lently coupled to CNBr-Sepharose 4B (Pharmacia). 
Immunohistochemistry and Immunofluorescence 
ImmunohistochemicaJ analyses were performed on 12 ~m frozen sec- 
tions of mouse brain fixed for 2 min in 1:1 acetone:methanol as pre- 
viously described (Buckanovich et al., 1993). Confocal images were 
collected using a Bio-Rad confocal microscope. 
Northern Blot Analysis and In Situ Hybridization 
Antisense riboprobe prepared by in vitro transcription from linearized 
pNB1 with T7 RNA polymerase (specific activity of 109 cpm/l~g) was 
used for Northen blot analysis as described previously (Buckanovich et 
al., 1993). In situ hybridization was performed essentially as described 
(Gibbs and Pfaff, 1994) using 33p-labeled sense and antisense ribo- 
probes transcribed from a mouse 15-NAP cDNA containing the 5'-most 
1.9 kb of the cDNA. 
Western Blot, Immunoprecipitation, and Phosphorylation 
r-NAP was detected from mouse brain extracts prepared in NET buffer 
(0.1% NP-40, 0.15 M NaCI, 50 mM Tris-HCl[pH 7.4]) with protease 
inhibitors (100 #g/ml aprotinin, 0.5 mM PMSF, 10 #g/ml leupeptin). 
Proteins were electrophoresed on 10% SDS-polyacrylamide gels and 
detected with either 12Sl-labeled protein A as described previously (Dar- 
nell et al, 1991) or a nonradioactive detection system (ECL; Amersham). 
For subcellular fractionations, mouse brains were lysed in hypotonic 
buffer (10 mM HEPES [pH 8.0], 1.5 mM MgCI2, 10 mM KCI, 1 mM 
DTT with protease inhibitors), and supernatant from a 15,000 x g 
centrifugation was separated into cytoplasmic and membrane frac- 
tions by centrifugation at 100,000 x g for 40 min. 
For phosphorylation assays, mouse brains were lysed in NET or 
BIPA (0.15 M NaCI, 1% Triton X-100, 0.5% Dec, 0.1% SDS, 0.05 M 
Tris-HCI [pH 7.5]) buffer with protease inhibitors and 0.1 mM NaV04; 
PKC buffer (20 mM Tris-HCI [pH 7.4], 10 mM MgOAc, 1 mM EGTA, 
2 mM DTT) and 100 mM ATP containing 100 #Ci of [y-32P]ATP (3000 
Ci/mmole; Amersham) were added, and reactions were incubated at 
30°C for 5 min. Immunoprecipitates were washed and analyzed by 
SDS-PAGE and autoradiography. For in vivo phosphorylation assays, 
a small-cell lung cancer cell line, H209 (ATCC), was grown for 2 hr 
in phosphate-free RPMI medium and labeled with inorganic phosphate 
(32p, 1 mCi/ml; Amersham) for 3 hr, lysed in RIPA buffer, immunopre- 
cipitated with Nb antiserum, and analyzed by autoradiography. Phos- 
phoamino acid analysis was performed as described elsewhere (Nairn 
and Greengard, 1987). 
Synaptosome Analysis 
Synaptosomes were prepared from adult mouse brains using Percoll 
gradients as previously described (Dunkley et al, 1986). The protein 
concentration of each fraction was determined using the BCA reagent 
(Pierce), and equal amounts of total protein were analyzed by Western 
blot with polyclonal synapsin antibody (a gift from A. Nairn) and mono- 
clonal transferrin receptor (Amersham) and synaptophysin (SY38; Ac- 
curate Chemical and Scientific Corporation) antibodies. The synaptic 
vesicle blot was a gift from P. De Camilli. 
Isolation of Nerve-Terminal Vesicles 
Crude nerve-terminal vesicles (LP2 fractions) from 60 mouse brains 
were resuspended in buffer 88 (20 mM K-HEPES, 0.25 M sorbitol, 
0.15 M KOAc, 1 mM MgOAc [pH 6.8]) and centrifuged at 14,000 x 
g for 5 rain, and the supernatants were loaded onto a 77 ml Sephacryl 
$1000 column (40 cm x 1.6 cm) equilibrated with buffer 88. Column 
fractions (2.0 ml) were analyzed by directly spotting 15 p.I onto prewet 
nitrocellulose filters using a 96-well dot blot apparatus (Schleicher & 
Schuell); filters were blocked with 5°/o milk in PBS, incubated with 
primary antibodies, and detected with ECL. 
Electron Microscopy 
Synaptosomes were fixed in 4.0% paraformaldehyde, 0.5% glutaral- 
dehyde for 30 min, dehydrated, and embedded in L. R. White resin 
(Electron Microscopy Science). Pale gold sections were collected on 
nickel grids, incubated with affinity-purified rabbit Nb antiserum at 1: 
100 dilution, and probed with goat anti-rabbit antiserum conjugated 
to 10 nm gold (Amersham). For cryoultramicrotomy, P2 fractions fixed 
as described above were infused with 2.3 M sucrose, processed as 
described previously (Tokuyasu, 1986), and probed with 10 nm gold- 
labeled rabbit antiserum. For analysis of $1000 column fractions, vesi- 
cles were concentrated by centrifugation at 134,000 x g for 2 hr and 
resuspended in one twentieth volume of buffer 88, followed by addition 
of gold-conjugated Nb antibody. Samples were incubated overnight 
at 4°C, applied directly to nickel grids, and negative stained with 2% 
ammonium molybdate (pH 7.0). 
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